Mills Clinical Research

What Mills Clinical Research does

Mills Clinical Research is a privately held clinical trial site founded in 2002 and headquartered in West Hollywood, California, operating two physical research sites (9201 W. Sunset Blvd. Suite 812 and 8280 Santa Monica Blvd.). The company conducts Phase I–IV clinical trials on behalf of pharmaceutical sponsors (Gilead, GSK, Janssen, Moderna, ViiV, AstraZeneca, Merck) and CROs (IQVIA, Parexel, PPD, Covance, Icon), and has been extensively involved in NIH/NIAID-funded COVID-19 treatment and prevention trials. Its therapeutic focus centers on HIV treatment, HIV prevention (PrEP), sexually transmitted infection treatment, and medical device studies, with explicit emphasis on serving LGBTQ+ populations, people living with HIV, undocumented individuals, and uninsured patients in Los Angeles County.

The company's operational infrastructure includes an on-site CLIA- and COLA-certified moderate/high-complexity clinical laboratory (covering PCR viral load testing, plasmapheresis, PBMC processing, and immunology), on-site bone densitometry with a certified DEXA technologist, secure climate-controlled investigational product storage, and paperless EMR, CTMS, and regulatory management systems with remote monitoring and decentralized clinical trial (DCT) capability. Bilingual Spanish-English staffing, BSL-2 biosafety handling, and one-week central IRB turnaround support the operational backbone.

Mills Clinical Research earns revenue through project-based professional services fees for clinical trial conduct, paid by pharmaceutical sponsors and CROs per protocol, supplemented by government-funded research contracts from NIH/NIAID. Patient recruitment is community-led via health fairs, CBO/ASO outreach, the Men's Health Foundation and SoCal Men's Medical Group clinic network (four LA County locations), and direct bilingual phone/email enrollment, with participants receiving free medical care, free medications, no citizenship or insurance requirements, and per-protocol stipends. Over 22+ years the site has completed 120+ trials and built a 15,000+ patient database, and was notably selected by Johnson & Johnson as the only Los Angeles site for their global COVID-19 vaccine trial.

Name

Mills Clinical Research

Legal name

Mills Clinical Research

Website

https://millsclinicalresearch.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

Mills Clinical Research is a privately held clinical trial site in West Hollywood, California, conducting Phase I–IV trials for pharmaceutical sponsors, CROs, and NIH/NIAID, with a focus on HIV, PrEP, STI, and medical device studies for underserved LGBTQ+ and HIV-affected populations in Los Angeles County.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Clinical Trial Sample Collection & Site Phlebotomy Services (HLAGACAJ)

Keywords

• Clinical research services
• Infectious disease trials
• HIV clinical research
• Medical device trials
• Contract research services

Headquarters

HQ city

West Hollywood

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Clinical Trial Conduct Services for Pharmaceutical Sponsors: Mills Clinical Research conducts Phase I-IV clinical trials on behalf of pharmaceutical company sponsors (Gilead, GSK, Janssen, Moderna, ViiV, etc.) and CROs (IQVIA, Parexel, PPD, Covance, etc.), earning fees for participant enrollment, study execution, data collection, and regulatory compliance. Revenue is project-based per trial.
2. NIH/NIAID Government-Funded Research Contracts: Conducts NIH and NIAID clinical trials for COVID-19 treatment and prevention, indicating revenue from government research contracts. The company has been extensively involved in NIH/NIAID clinical trials.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Mills Clinical Research operates a clinical trial site that conducts Phase I-IV clinical trials on behalf of pharmaceutical sponsors (Gilead, GSK, Janssen, Moderna, ViiV) and contract research organizations (IQVIA, Parexel, PPD, Covance), as well as NIH/NIAID-funded trials. The site recruits and enrolls participants in Los Angeles County through community outreach and referrals from its affiliated Men's Health Foundation clinics, and executes trial protocols using its on-site CLIA/COLA-certified lab, DEXA bone densitometry, BSL-2 biosafety handling, and paperless EMR/CTMS/regulatory management system. Trial areas include HIV treatment, HIV prevention (PrEP), sexually transmitted infections, and medical devices.

Product overview

Mills Clinical Research operates as a clinical research site offering four main service lines: HIV Treatment Trials, HIV Prevention (PrEP) Trials, STI Treatment Trials, and Medical Device Trials. The organization partners with Men's Health Foundation and is part of SoCal Men's Medical Group, serving the Los Angeles community for over 22 years with more than 120 clinical trials completed. Participants receive free medical consulting, medications, and compensation for their involvement.

Differentiator

Problem solved

Functional benefit

Products and services

• HIV Treatment Trials Phase I-IV clinical trials evaluating new and experimental treatments for HIV, providing participants access to cutting-edge medications before they are commercially available; delivered for pharmaceutical sponsors and CROs at the West Hollywood sites.
• HIV Prevention (PrEP) Trials Clinical trials focused on HIV prevention through pre-exposure prophylaxis (PrEP) medications and strategies, conducted on behalf of pharmaceutical sponsors and CROs for at-risk populations in Los Angeles.
• STI Treatment Trials Clinical trials evaluating treatments for sexually transmitted infections, executed on behalf of pharmaceutical sponsors and CROs at the West Hollywood clinical research sites.
• Medical Device Trials Clinical trials for medical devices, including RSV vaccine and other device studies, conducted on behalf of pharmaceutical and medical device sponsors at Mills Clinical Research sites.

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

14 partnerships are on record, tiered core, flagship and minor.

• Men's Health FoundationcoreStrategic or Co-development PartnerMen's Health Foundation is the core affiliate of Mills Clinical Research. The Foundation's clinics are at the center of services designed to combat health inequity. Mills Clinical Research is the clinical research arm of Men's Health Foundation, enabling access to cutting-edge treatments for Foundation patients. Dr. Anthony Mills serves as CEO of Men's Health Foundation as well as CEO of Mills Clinical Research.
• SoCal Men's Medical GroupcoreStrategic or Co-development PartnerMills Clinical Research is part of SoCal Men's Medical Group which has four locations across Los Angeles County. This partnership allows access to diverse patient populations and integrated care pathways for clinical trial referrals.
• Johnson & Johnson (Janssen)flagshipStrategic or Co-development PartnerJohnson & Johnson selected Mills Clinical Research as the only site in Los Angeles to participate in their global COVID-19 vaccine trial, with a special focus on communities with barriers to healthcare.
• Gilead SciencescoreStrategic or Co-development PartnerPharmaceutical sponsor of HIV treatment and prevention clinical trials conducted at Mills Clinical Research.
• GSKcoreStrategic or Co-development PartnerPharmaceutical sponsor of clinical trials conducted at Mills Clinical Research.
• ViiV HealthcarecoreStrategic or Co-development PartnerPharmaceutical sponsor of HIV-focused clinical trials conducted at Mills Clinical Research.
• ModernacoreStrategic or Co-development PartnerPharmaceutical sponsor of clinical trials conducted at Mills Clinical Research.
• IQVIAcoreImplementation/ SI/ Consulting PartnerMajor CRO (Contract Research Organization) partner managing clinical trials that are executed at Mills Clinical Research sites.
• ParexelcoreImplementation/ SI/ Consulting PartnerMajor CRO partner managing clinical trials executed at Mills Clinical Research sites.
• PPD (Pharma Partners Development)coreImplementation/ SI/ Consulting PartnerCRO partner managing clinical trials executed at Mills Clinical Research sites.
• CovancecoreImplementation/ SI/ Consulting PartnerCRO partner managing clinical trials executed at Mills Clinical Research sites.
• AstraZenecaminorStrategic or Co-development PartnerPharmaceutical sponsor listed as a partner/sponsor of clinical trials.
• MerckminorStrategic or Co-development PartnerPharmaceutical sponsor listed as a partner/sponsor of clinical trials.
• JanssenminorStrategic or Co-development PartnerPharmaceutical sponsor listed as a partner/sponsor of clinical trials.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ICON plc (incl. PRA Health): Global CRO with a large dedicated site and decentralized trial network. Incumbent comparable that increasingly bundles site services into sponsor contracts, raising competitive pressure on independent two-site operators like Mills.
• QPS Holdings: Global CRO/CDMO with clinical research site operations, including Phase I clinics. Broader, larger incumbent that competes with Mills for early-phase infectious disease and vaccine trials but at materially greater scale and geographic reach.

Emerging players

• Clinipace Worldwide: Mid-sized CRO with site management capabilities serving small-to-mid biotech sponsors. Comparable to Mills' CRO-facing engagement model but adds sponsor-facing CRO services on top of site execution.

Others

• Whitman-Walker Health: Community-based LGBTQ+ and HIV-focused health organization with a clinical research arm in Washington, D.C. Highly comparable to Mills' HIV/LGBTQ+ community-research model — and notably where Dr. Wm. David Hardy previously served as Senior Director of Research.
• AIDS Healthcare Foundation: Large global HIV/AIDS healthcare organization with U.S. clinical operations including in Los Angeles. Comparable as a community-trusted, HIV-focused organization with overlapping patient population and LA footprint, though it is primarily a care provider rather than a dedicated SMO.

Direct peers

• PMG Research: Multi-site independent clinical research site network operating dedicated research centers across the U.S. Like Mills, PMG runs therapeutic-specific trials (including infectious disease) on behalf of pharma sponsors and CROs and competes for the same site-selection decisions.
• Accel Research Sites: Network of dedicated clinical research sites conducting Phase I-IV trials for pharma and CROs. Comparable to Mills as an independent, multi-site SMO focused on diverse therapeutic areas and serving the same sponsor/CRO buyer set.
• AMR (Advanced Medical Research): Independent clinical research site network with multiple U.S. locations running Phase II-IV trials. Comparable as a sponsor-facing SMO that competes for the same Phase II/IV study placements as Mills.
• Meridien Research: Multi-site clinical research organization operating dedicated research centers across the U.S. Directly comparable to Mills in business model — independent sites executing pharma-sponsored trials across multiple therapeutic areas.
• DM Clinical Research: Multi-therapeutic clinical research site organization with multiple U.S. locations executing trials for pharmaceutical sponsors and CROs. Direct comparable to Mills' model of operating dedicated research sites outside of academic medical centers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights8 records

Customer concentration

• LinkedInlinkedin.com/company/mills-clinical-research

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mills Clinical Research